← Open Payments lookup

MICHELLE CHIN: Open Payments

NPI 1649645938 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,115 in 61 payments from 13 companies in 2025. Trend: 2023 $889 · 2024 $970 · 2025 $2,115

Food & beverage: $2,115
CompanyPaymentsAmount
ABBVIE INC.19$505
Otsuka America Pharmaceutical, Inc.9$358
Neurocrine BioSciences, Inc.4$307
Vanda Pharmaceuticals Inc.9$237
E.R. Squibb & Sons, L.L.C.3$167
Janssen Pharmaceuticals, Inc2$147
Teva Pharmaceuticals USA, Inc.2$136
Axsome Therapeutics, Inc.4$71
Alkermes, Inc.4$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$54

Products named: VRAYLAR, INGREZZA, FANAPT, REXULTI, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY MAINTENA.

Industry payments across ID — which companies pay providers there.